These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 19744586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Weimer ET, Lu H, Kock ND, Wozniak DJ, Mizel SB.
    Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M, Sun C, Gu J, Yan X, Wang B, Cui Z, Sun X, Tong C, Feng X, Lei L, Han W.
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [Abstract] [Full Text] [Related]

  • 6. Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.
    Bumann D, Behre C, Behre K, Herz S, Gewecke B, Gessner JE, von Specht BU, Baumann U.
    Vaccine; 2010 Jan 08; 28(3):707-13. PubMed ID: 19887136
    [Abstract] [Full Text] [Related]

  • 7. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
    Kaloshin AA, Mikhaĭlova NA, Leonova EI.
    Zh Mikrobiol Epidemiol Immunobiol; 2012 Jan 08; (3):35-43. PubMed ID: 22830272
    [Abstract] [Full Text] [Related]

  • 8. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z, Han D, Sun X, Zhang M, Feng X, Sun C, Gu J, Tong C, Lei L, Han W.
    Appl Microbiol Biotechnol; 2015 Jan 08; 99(2):667-80. PubMed ID: 25381907
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K, Wiener-Kronish JP, Sawa T.
    Microbiol Immunol; 2009 Nov 08; 53(11):587-94. PubMed ID: 19903258
    [Abstract] [Full Text] [Related]

  • 10. [Construction of recombinant Bb(pGEX-OprF-I) vaccine of Pseudomonas aeruginosa and its protection elicited in mice].
    Liang C, Li W.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul 08; 35(7):589-594. PubMed ID: 31537242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Study on Construction of Recombinant Bb-pGEX-OprI Vaccine of Pseudomonas aeruginosa and Its Protection Effect].
    Liu X, Li WG, Luo GX.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan 08; 49(1):13-17. PubMed ID: 29737082
    [Abstract] [Full Text] [Related]

  • 14. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
    Arnold H, Bumann D, Felies M, Gewecke B, Sörensen M, Gessner JE, Freihorst J, von Specht BU, Baumann U.
    Infect Immun; 2004 Nov 08; 72(11):6546-53. PubMed ID: 15501786
    [Abstract] [Full Text] [Related]

  • 15. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U, Mansouri E, von Specht BU.
    Vaccine; 2004 Feb 17; 22(7):840-7. PubMed ID: 15040936
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, Mahdavi M.
    APMIS; 2014 Feb 17; 122(2):115-27. PubMed ID: 23758581
    [Abstract] [Full Text] [Related]

  • 17. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
    Mansouri E, Blome-Eberwein S, Gabelsberger J, Germann G, von Specht BU.
    FEMS Immunol Med Microbiol; 2003 Jul 15; 37(2-3):161-6. PubMed ID: 12832120
    [Abstract] [Full Text] [Related]

  • 18. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J, Knapp B, Bauersachs S, Enz UI, von Specht BU, Domdey H.
    Behring Inst Mitt; 1997 Feb 15; (98):302-14. PubMed ID: 9382754
    [Abstract] [Full Text] [Related]

  • 19. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S, Sattari M, Mahdavi M, Roudkenar MH.
    Burns; 2011 Aug 15; 37(5):865-72. PubMed ID: 21334822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.